Krebs Biochemicals & Industries Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Net Loss of Krebs Biochemicals & Industries reported to Rs 2.34 crore in the quarter ended March 2026 as against net loss of Rs 8.27 crore during the previous quarter ended March 2025. Sales rose 11.64% to Rs 6.81 crore in the quarter ended March 2026 as against Rs 6.10 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 16.93 crore in the year ended March 2026 as against net loss of Rs 26.94 crore during the previous year ended March 2025. Sales declined 45.21% to Rs 23.73 crore in the year ended March 2026 as against Rs 43.31 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Alpa Laboratories Ltd, STL Global Ltd, Next Mediaworks Ltd and Sakuma Exports Ltd are among the other gainers in the BSE's 'B' group today, 06 April 2026.

Krebs Biochemicals & Industries Ltd spiked 20.00% to Rs 54.72 at 11:58 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 3462 shares were traded on the counter so far as against the average daily volumes of 3018 shares in the past one month.

Alpa Laboratories Ltd soared 20.00% to Rs 61.87. The stock was the second biggest gainer in 'B' group. On the BSE, 1799 shares were traded on the counter so far as against the average daily volumes of 3854 shares in the past one month.

STL Global Ltd surged 19.94% to Rs 11.37. The stock was the third biggest gainer in 'B' group. On the BSE, 9563 shares were traded on the counter so far as against the average daily volumes of 2112 shares in the past one month.

Next Mediaworks Ltd advanced 19.03% to Rs 4.19. The stock was the fourth biggest gainer in 'B' group. On the BSE, 558 shares were traded on the counter so far as against the average daily volumes of 13951 shares in the past one month.

Sakuma Exports Ltd gained 17.50% to Rs 1.88. The stock was the fifth biggest gainer in 'B' group. On the BSE, 19.52 lakh shares were traded on the counter so far as against the average daily volumes of 5.78 lakh shares in the past one month.

Net Loss of Krebs Biochemicals & Industries reported to Rs 3.13 crore in the quarter ended December 2025 as against net loss of Rs 7.74 crore during the previous quarter ended December 2024. Sales declined 36.62% to Rs 7.27 crore in the quarter ended December 2025 as against Rs 11.47 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News